David Luyimbazi

523 total citations
20 papers, 372 citations indexed

About

David Luyimbazi is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, David Luyimbazi has authored 20 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in David Luyimbazi's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Treatment and Pharmacology (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). David Luyimbazi is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Treatment and Pharmacology (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). David Luyimbazi collaborates with scholars based in United States, Taiwan and Hungary. David Luyimbazi's co-authors include Argun Akçakanat, Gopal K. Singh, Funda Meric‐Bernstam, Ana M. González-Angulo, Yuhuan Zheng, Douglas J. Grider, Farrell Adkins, Curtis E. Bower, Irving C. Allen and Eli Vlaisavljevich and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

David Luyimbazi

20 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Luyimbazi United States 10 166 72 67 57 44 20 372
Jayendra B. Patel India 12 195 1.2× 104 1.4× 45 0.7× 104 1.8× 20 0.5× 24 448
Julien Fernandes France 10 140 0.8× 65 0.9× 78 1.2× 66 1.2× 42 1.0× 18 376
Miguel Marino United States 4 155 0.9× 192 2.7× 27 0.4× 102 1.8× 44 1.0× 4 467
Weijuan Li China 12 171 1.0× 88 1.2× 24 0.4× 62 1.1× 36 0.8× 26 428
Mengtong Xu China 4 160 1.0× 74 1.0× 20 0.3× 84 1.5× 46 1.0× 11 339
Elmira Gheytanchi Iran 12 183 1.1× 170 2.4× 49 0.7× 94 1.6× 63 1.4× 26 394
Lyndsay Smith United States 11 169 1.0× 136 1.9× 42 0.6× 132 2.3× 23 0.5× 14 451
Ya‐Wen Cheng Taiwan 14 187 1.1× 110 1.5× 32 0.5× 97 1.7× 57 1.3× 19 479
Hari Nadiminti United States 8 95 0.6× 121 1.7× 40 0.6× 54 0.9× 50 1.1× 15 358

Countries citing papers authored by David Luyimbazi

Since Specialization
Citations

This map shows the geographic impact of David Luyimbazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Luyimbazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Luyimbazi more than expected).

Fields of papers citing papers by David Luyimbazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Luyimbazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Luyimbazi. The network helps show where David Luyimbazi may publish in the future.

Co-authorship network of co-authors of David Luyimbazi

This figure shows the co-authorship network connecting the top 25 collaborators of David Luyimbazi. A scholar is included among the top collaborators of David Luyimbazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Luyimbazi. David Luyimbazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imran, Khan Mohammad, Michael Edwards, Neha Singh, et al.. (2023). Ultrasound-guided noninvasive pancreas ablation using histotripsy: feasibility study in an in vivo porcine model. International Journal of Hyperthermia. 40(1). 2247187–2247187. 9 indexed citations
2.
Imran, Khan Mohammad, Jessica M. Gannon, Holly A. Morrison, et al.. (2023). Successful In Situ Targeting of Pancreatic Tumors in a Novel Orthotopic Porcine Model Using Histotripsy. Ultrasound in Medicine & Biology. 49(11). 2361–2370. 5 indexed citations
3.
Grider, Douglas J., et al.. (2021). Histotripsy for the Treatment of Cholangiocarcinoma in a Patient-Derived Xenograft Mouse Model. Ultrasound in Medicine & Biology. 48(2). 293–303. 11 indexed citations
4.
Simon, Alex, Sheryl Coutermarsh‐Ott, Douglas J. Grider, et al.. (2021). Histotripsy for the Treatment of Cholangiocarcinoma Liver Tumors: In Vivo Feasibility and Ex Vivo Dosimetry Study. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control. 68(9). 2953–2964. 29 indexed citations
5.
Luyimbazi, David, et al.. (2021). Rare mimic of angiosarcoma: Erythema ab igne with reactive angiomatosis. Journal of Cutaneous Pathology. 48(10). 1298–1302. 2 indexed citations
6.
Luyimbazi, David, et al.. (2019). Epidermoid Cysts in a Wandering Spleen: An Unusual Enigma. SHILAP Revista de lepidopterología. 2019(1). 1581736–1581736. 2 indexed citations
7.
Luyimbazi, David, et al.. (2019). Pancreatic Inflammatory Pseudotumor-Like Follicular Dendritic Cell Tumor. SHILAP Revista de lepidopterología. 2019. 1–5. 15 indexed citations
8.
Wen, Wei, David Luyimbazi, Thehang Luu, et al.. (2019). Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer. Cells. 8(9). 1010–1010. 25 indexed citations
9.
Adkins, Farrell, et al.. (2018). Small Bowel Obstruction. Surgical Clinics of North America. 98(5). 945–971. 46 indexed citations
10.
Luyimbazi, David, et al.. (2017). Metastatic basal cell carcinoma with loss of p63 and mismatch repair proteins. JAAD Case Reports. 3(3). 222–224. 4 indexed citations
11.
Luyimbazi, David, Rebecca A. Nelson, Audrey H. Choi, et al.. (2014). Estimates of Conditional Survival in Gastric Cancer Reveal a Reduction of Racial Disparities with Long-Term Follow-Up. Journal of Gastrointestinal Surgery. 19(2). 251–257. 11 indexed citations
12.
Luyimbazi, David, Rebecca A. Nelson, Steven L. Chen, & Joseph Kim. (2013). Conditional survival in gastric cancer: Does race influence prognosis in long-term survivors?. Journal of Clinical Oncology. 31(4_suppl). 22–22. 1 indexed citations
13.
14.
15.
Luyimbazi, David, Thehang Luu, Jin Yan, et al.. (2013). Effect of eribulin on cell growth and PI3K pathway activity with and without RAD001 in triple-negative and HER2-expressing breast cancer.. Journal of Clinical Oncology. 31(26_suppl). 173–173. 5 indexed citations
16.
Singh, Gopal K., et al.. (2011). The Effect of Leucine Restriction on Akt/mTOR Signaling in Breast Cancer Cell Lines In Vitro and In Vivo. Nutrition and Cancer. 63(2). 264–271. 17 indexed citations
17.
Luyimbazi, David, Argun Akçakanat, Priscilla F. McAuliffe, et al.. (2010). Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast Cancer. Molecular Cancer Therapeutics. 9(10). 2770–2784. 60 indexed citations
18.
Luyimbazi, David, Argun Akçakanat, Li Zhang, Yuhuan Zheng, & Funda Meric‐Bernstam. (2009). Mammalian target of rapamycin (mTOR) and eIF4E regulate stearoyl CoA desaturase 1 expression through modulation of SREBP1 in breast cancer cell lines. Journal of the American College of Surgeons. 209(3). S120–S120. 1 indexed citations
19.
Akçakanat, Argun, Gopal K. Singh, David Luyimbazi, et al.. (2008). eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling. Molecular Cancer Therapeutics. 7(7). 1782–1788. 80 indexed citations
20.
Spatafora, Grace, et al.. (1999). Regulated Expression of the Streptococcus mutans dlt Genes Correlates with Intracellular Polysaccharide Accumulation. Journal of Bacteriology. 181(8). 2363–2372. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jayendra B. Patel Breakdown of academic impact, for papers by Julien Fernandes Breakdown of academic impact, for papers by Miguel Marino Breakdown of academic impact, for papers by Weijuan Li Breakdown of academic impact, for papers by Mengtong Xu Breakdown of academic impact, for papers by Elmira Gheytanchi Breakdown of academic impact, for papers by Lyndsay Smith Breakdown of academic impact, for papers by Ya‐Wen Cheng Breakdown of academic impact, for papers by Hari Nadiminti
Rankless by CCL
2026